Cohance Lifesciences Shareholders Approve All Resolutions at 8th AGM
Cohance Lifesciences Ltd 路 Annual General Meeting 路 18 Sept 2026, 1:29 am
Cohance Lifesciences Shareholders Approve All Resolutions at 8th AGM Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) announced the successful passage of all ordinary resolutions at its 8th AGM held on 17th Sep'26. Shareholders approved the standalone and consolidated financial statements for FY25-26 with 99.9992% majority votes in favour. Additionally, the reappointment of Ms. Shweta Jalan as a director liable to retire by rotation was approved with 99.9731% voting in favour. Total voter turnout stood at 82.8877% of outstanding shares (317.13m votes polled out of 382.60m shares).
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
